CERDELGA (eliglustat) capsules

Cerdelga (Eliglustat)

CERDELGA

eliglustat

84 mg capsules

Genzyme Corporation

Medical Use

CERDELGA is a glucosylceramide synthase inhibitor used for the long-term treatment of adult patients with Gaucher disease type 1 who are identified as CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) through an FDA-cleared test.

Limitations of Use:

  • -CYP2D6 ultra-rapid metabolizers may not reach sufficient concentrations of CERDELGA for a therapeutic effect.
  • -A specific dosage cannot be recommended for CYP2D6 indeterminate metabolizers.